Inactive Instrument

Gelesis Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline	15-07-27	GL
Gelesis Presents Additional Data at European Congress on Obesity	15-05-22	GL

Managers	Title	Age	Since
David Pass COO	Chief Operating Officer	56	16-08-31
Angelo Tremblay PRN	Corporate Officer/Principal	-	-
Cosimo Saponaro PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Clayton Christopher BRD	Director/Board Member	51	-
Kathryn Cavanaugh BRD	Director/Board Member	50	21-12-31
Alison Bauerlein BRD	Director/Board Member	42	22-01-04

Sector

	1st Jan change	Capi.
CSL LIMITED	-2.86%	87.31B
SAMSUNG BIOLOGICS CO.,LTD.	+3.95%	40.86B
BIOGEN INC.	-21.94%	29.36B
UCB	+54.31%	24.49B
BIOMARIN PHARMACEUTICAL INC.	-5.41%	17.31B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-44.23%	11.26B
INCYTE CORPORATION	-17.60%	11.62B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-13.96%	11.31B
SWEDISH ORPHAN BIOVITRUM AB	+7.34%	8.31B